Continuous Membrane-Assisted Crystallization To Increase the Attainable Product Quality of Pharmaceuticals and Design Space for Operation

Continuous manufacturing is an important paradigm shift in pharmaceutical industries and has renewed the interest in continuous crystallization. The combination of crystallization and membranes is a promising hybrid technology for separation and purification of pharmaceuticals. The impact of membranes as an extension to conventional continuous crystallization processes on attainable product quality and design space is investigated systematically using model-based optimization. The proposed model is based on a full population balance such that all relevant crystallization phenomena can be included and is solved using a first-order discretization scheme with a hybrid grid. A case study involving continuous crystallization of paracetamol using a series of mixed suspension, mixed product removal (MSMPR) crystallizers is presented to illustrate the approach. The results show that the attainable size and design space can be enlarged significantly by extending conventional crystallization with membranes. In part...

[1]  Arne Drud,et al.  CONOPT: A GRG code for large sparse dynamic nonlinear optimization problems , 1985, Math. Program..

[2]  D. Ramkrishna.  The Status of Population Balances , 1985 .

[3]  Gyorgy Szekely,et al.  Molecular separation with organic solvent nanofiltration: a critical review. , 2014, Chemical reviews.

[4]  Zoltan K. Nagy,et al.  Fines removal in a continuous plug flow crystallizer by optimal spatial temperature profiles with controlled dissolution , 2013 .

[5]  Peter J.T. Verheijen,et al.  Optimal Design of Solution Crystallization Processes with Rigorous Models , 2003 .

[6]  Allan S. Myerson,et al.  Development of Continuous Anti-Solvent/Cooling Crystallization Process using Cascaded Mixed Suspension, Mixed Product Removal Crystallizers , 2012 .

[7]  Alan D. Randolph,et al.  SELECTIVE FINES DESTRUCTION IN BATCH CRYSTALLIZATION , 1989 .

[8]  Gerry Steele,et al.  Continuous Crystallization of Pharmaceuticals Using a Continuous Oscillatory Baffled Crystallizer , 2009 .

[9]  Richard Lakerveld,et al.  Application of generic principles of process intensification to solution crystallization enabled by a task-based design approach , 2010 .

[10]  Richard D. Braatz,et al.  First-principles and direct design approaches for the control of pharmaceutical crystallization , 2005 .

[11]  K. Plumb,et al.  Continuous Processing in the Pharmaceutical Industry: Changing the Mind Set , 2005 .

[12]  Johan Grievink,et al.  Characterization and Dynamic Optimization of Membrane-Assisted Crystallization of Adipic Acid , 2009 .

[13]  M. W. Wood-Kaczmar,et al.  Use of focused beam reflectance measurement (FBRM) and process video imaging (PVI) in a modified mixed suspension mixed product removal (MSMPR) cooling crystallizer , 2005 .

[14]  Patrick J. Frawley,et al.  Estimation of the growth kinetics for the cooling crystallisation of paracetamol and ethanol solutions , 2011 .

[15]  Allan S. Myerson,et al.  Control of Polymorphism in Continuous Crystallization via Mixed Suspension Mixed Product Removal Systems Cascade Design , 2015 .

[16]  Johan Grievink,et al.  Membrane assisted crystallization using reverse osmosis: Influence of solubility characteristics on experimental application and energy saving potential , 2010 .

[17]  A. Behr,et al.  New Developments in Chemical Engineering for the Production of Drug Substances , 2004 .

[18]  Jérôme Mantanus,et al.  Design space approach in the optimization of the spray-drying process. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  Enrico Drioli,et al.  Antisolvent membrane crystallization of pharmaceutical compounds. , 2009, Journal of pharmaceutical sciences.

[20]  Richard D. Braatz,et al.  Robust optimal control for the maximization of design space , 2015, 2015 American Control Conference (ACC).

[21]  Johannes G Khinast,et al.  An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  M. Statman,et al.  The effect of patent expiration on the market position of drugs , 1981 .

[23]  Patrick J. Frawley,et al.  Nucleation kinetics of paracetamol–ethanol solutions from metastable zone widths , 2010 .

[24]  Dominique M. Roberge,et al.  Microreactor Technology: A Revolution for the Fine Chemical and Pharmaceutical Industries? , 2005 .

[25]  Luis A. Cisternas,et al.  Design of separation schemes for fractional crystallization of metathetical salts , 2003 .

[26]  J. Seinfeld,et al.  Numerical solution of the dynamic equation for particulate systems , 1978 .

[27]  B. Shekunov,et al.  CRYSTALLIZATION PROCESSES IN PHARMACEUTICAL TECHNOLOGY AND DRUG DELIVERY DESIGN , 2000 .

[28]  Andrew G. Livingston,et al.  Use of Continuous MSMPR Crystallization with Integrated Nanofiltration Membrane Recycle for Enhanced Yield and Purity in API Crystallization , 2014 .

[29]  G. He,et al.  Membrane assisted cooling crystallization: Process model, nucleation, metastable zone, and crystal size distribution , 2016 .

[30]  Allan S. Myerson,et al.  Crystallization of Cyclosporine in a Multistage Continuous MSMPR Crystallizer , 2011 .

[31]  Rafiqul Gani,et al.  Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  Andre Raw,et al.  Quality by Design: Concepts for ANDAs , 2008, The AAPS Journal.

[33]  Narayan Variankaval,et al.  From Form to Function: Crystallization of Active Pharmaceutical Ingredients , 2008 .

[34]  H Leuenberger,et al.  New trends in the production of pharmaceutical granules: batch versus continuous processing. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  J. D. Ward,et al.  Choosing an operating policy for seeded batch crystallization , 2006 .

[36]  M. Hounslow.  A discretized population balance for continuous systems at steady state , 1990 .

[37]  H. Wu,et al.  Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. , 2011, International journal of pharmaceutics.

[38]  Christopher L. Burcham,et al.  Designing Robust Crystallization Processes in the Presence of Parameter Uncertainty Using Attainable Regions , 2015 .

[39]  Ravendra Singh,et al.  Multi-scale flowsheet simulation of an integrated continuous purification-downstream pharmaceutical manufacturing process. , 2013, International journal of pharmaceutics.

[40]  M. Hounslow,et al.  A discretized population balance for nucleation, growth, and aggregation , 1988 .

[41]  Kurt Brorson,et al.  A design space exploration for control of Critical Quality Attributes of mAb. , 2016, International journal of pharmaceutics.

[42]  Xiangyang Wang,et al.  Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation , 2008, Biotechnology progress.

[43]  Richard D Braatz,et al.  Advances and new directions in crystallization control. , 2012, Annual review of chemical and biomolecular engineering.

[44]  P. V. D. Hof,et al.  A control oriented study on the numerical solution of the population balance equation for crystallization processes , 2009 .

[45]  Lawrence X. Yu.  Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.

[46]  Richard D. Braatz,et al.  Model‐based design of a plant‐wide control strategy for a continuous pharmaceutical plant , 2013 .

[47]  Davide Fissore,et al.  On the use of mathematical models to build the design space for the primary drying phase of a pharmaceutical lyophilization process. , 2011, Journal of pharmaceutical sciences.

[48]  Richard D. Braatz,et al.  A model-based approach for the construction of design spaces in quality-by-design , 2012, 2012 American Control Conference (ACC).

[49]  K. Sirkar,et al.  Polymeric Hollow Fiber Heat Exchangers: An Alternative for Lower Temperature Applications , 2004 .

[50]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[51]  David J.W. Grant,et al.  Solid-state pharmaceutical chemistry , 1994 .

[52]  S. Y. Wong,et al.  On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system , 2016, Science.

[53]  Allan S. Myerson,et al.  Continuous Plug Flow Crystallization of Pharmaceutical Compounds , 2010 .

[54]  M. A. Larson,et al.  Transient and steady state size distributions in continuous mixed suspension crystallizers , 1962 .

[55]  Enrico Drioli,et al.  Process intensification strategies and membrane engineering , 2012 .

[56]  James M. B. Evans,et al.  End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. , 2013, Angewandte Chemie.

[57]  D. Grant,et al.  Crystallisation of paracetamol (acetaminophen) in the presence of structurally related substances , 1998 .

[58]  J. Macgregor,et al.  A Framework for the Development of Design and Control Spaces , 2008, Journal of Pharmaceutical Innovation.

[59]  S. Y. Wong,et al.  Development of Continuous Crystallization Processes Using a Single-Stage Mixed-Suspension, Mixed-Product Removal Crystallizer with Recycle , 2012 .

[60]  Michael R. Bussieck,et al.  General Algebraic Modeling System (GAMS) , 2004 .

[61]  Dimitrios I. Gerogiorgis,et al.  Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study , 2011 .

[62]  Christianto Wibowo,et al.  Synthesis of crystallization processes for systems involving solid solutions , 2008, Comput. Chem. Eng..

[63]  Ahmad Y. Sheikh,et al.  Optimal synthesis of stagewise continuous crystallization process networks , 1998 .

[64]  Enrico Drioli,et al.  A new membrane-based crystallization technique: tests on lysozyme , 2003 .

[65]  Enrico Drioli,et al.  New Metrics for Evaluating the Performance of Membrane Operations in the Logic of Process Intensification , 2007 .

[66]  Christopher L. Burcham,et al.  Regions of attainable particle sizes in continuous and batch crystallization processes , 2014 .

[67]  Sze Kee Tam,et al.  Design of Protein Crystallization Processes Guided by Phase Diagrams , 2011 .

[68]  Yang Yang,et al.  Advanced control approaches for combined cooling/antisolvent crystallization in continuous mixed suspension mixed product removal cascade crystallizers , 2015 .

[69]  Brian Glennon,et al.  Design and optimization of a multistage continuous cooling mixed suspension, mixed product removal crystallizer , 2015 .

[70]  Anthony G. Fane,et al.  Membrane distillation crystallization of concentrated salts—flux and crystal formation , 2005 .

[71]  Kieran W Hutton,et al.  The effects of supersaturation, temperature, agitation and seed surface area on the secondary nucleation of paracetamol in ethanol solutions , 2012 .